Are you sure?

Human BioPlazma receives HUF 350 million of support

  Hungary's government has granted biological-medicine company Human BioPlazma HUF 350 million (€1.25 million) in non-repayable investment support for expansion of its plant in Gödöllő, just northeast of Budapest, the most recent issue of the official Economic Gazette revealed.


The company expects to complete the HUF 5 billion expansion project begun last year by 2011.

Human BioPlazma plans to hire 60 new employees as a result of the project, which will double the company's production capacity of plasma-based medication to 550,00 liters per year. (MTI-ECONEWS)